Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Brain Neoplasms 12Cognitive Dysfunction 4Radiation Injuries 3Neoplasms 3Multiple Myeloma 3Glioma 3Lymphoma, B-Cell 2Lymphoma 2Glioblastoma 2Fatigue 2Breast Neoplasms 2Astrocytoma 2Triple Negative Breast Neoplasms 1Stroke 1Sarcoma 1Pituitary Neoplasms 1Parkinson Disease 1Osteosarcoma 1Oligodendroglioma 1Neurotoxicity Syndromes 1Neurofibromatosis 1 1Neoplasm Metastasis 1Meningioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Localized, Operable Non-small Cell Lung Cancer 1Liver Neoplasms 1Liver Diseases 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Neuropsychological Tests × Clear all
NCT00550134 2021-12-30

Cognitive Changes Associated With Breast Cancer Treatment

Memorial Sloan Kettering Cancer Center

Completed
53 enrolled
Breast

Breast Neoplasms

NCT01332916 2014-04-25

CANMEM

Centre Francois Baclesse

Phase 2 Terminated
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡